All Posts
RCT | Safety of integrated MDA of azithromycin, albendazole and ivermectin vs. standard treatment regimens
10 May, 2023 | 15:24h | UTC
Consensus Statement | Comprehensive type 2 diabetes management algorithm – 2023 update
9 May, 2023 | 15:10h | UTCRelated: Guideline | ADA 2023 Standards of Medical Care in Diabetes
Consensus | Addressing stigma/bias in diagnosing, managing obesity-based chronic disease, and evaluating determinants of severity
9 May, 2023 | 15:08h | UTC
Study shows unenhanced CT shows 30% lower diagnostic accuracy in abdominal pain evaluation
9 May, 2023 | 15:02h | UTCDiagnostic Accuracy of Unenhanced Computed Tomography for Evaluation of Acute Abdominal Pain in the Emergency Department – JAMA Surgery (free for a limited period)
Editorial: Intravenous Contrast in Computed Tomography Imaging for Acute Abdominal Pain – JAMA Surgery (free for a limited period)
Commentary: New data suggest clinicians should think twice before foregoing contrast-enhanced imaging – Health Imaging
Commentary on Twitter
In a general population of emergency department patients with abdominal pain, using unenhanced CT to avoid risks of intravenous contrast medium administration is associated with a large diagnostic penalty. https://t.co/CVg04763yd
— JAMA Surgery (@JAMASurgery) May 3, 2023
Video | Keeping up with the literature: special discussion of masking evidence
9 May, 2023 | 14:56h | UTCKeeping up with the literature | Special discussion of Masking Evidence
RCT | Early treatment of gestational diabetes slightly lowers risk of adverse neonatal outcomes
9 May, 2023 | 14:55h | UTCTreatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Early treatment of gestational diabetes for those at higher risk beneficial, study finds – Western Sidney University
RCT | Morning discharge prioritization fails to shorten hospital stay or expedite orders
9 May, 2023 | 14:58h | UTCCommentary: “Discharge Before Noon”: Time to Jump Off the Bandwagon? – Physician’s First Watch
Review | Therapeutics for COVID-19
9 May, 2023 | 14:53h | UTCTherapeutics for COVID-19 – Nature Microbiology
Commentary on Twitter
?New Perspective out now:
Therapeutics for COVID-19
By Sima Toussi, Jennifer Hammond, Brian Gerstenberger & Annaliesa Andersonhttps://t.co/WNJzkFMFuF
— Nature Microbiology (@NatureMicrobiol) May 5, 2023
New ACR breast cancer screening guidelines call for earlier and more-intensive screening for high-risk women
9 May, 2023 | 14:50h | UTCGuideline: Breast Cancer Screening for Women at Higher-than-Average Risk: Updated Recommendations from the ACR
Cohort Study | Limited evidence linking COVID-19 vaccines to menstrual disturbance or postmenopausal bleeding
9 May, 2023 | 14:52h | UTCNews Release: New study finds no increased risk of menstrual changes after covid-19 vaccination – BMJ Newsroom
Commentary: Large study shows no changes to menstrual cycles after COVID vaccination – CIDRAP
Related:
Editorial: Menstruation and Covid-19 vaccination.
Commentary on Twitter
The findings of this new study do not provide substantial support for a causal association between SARS-CoV-2 vaccination and healthcare contacts related to menstrual or bleeding disordershttps://t.co/Tsw2hjIiIz
— The BMJ (@bmj_latest) May 4, 2023
Effects of intraoperative fluorescence guidance for breast cancer lumpectomy surgery
9 May, 2023 | 14:48h | UTCIntraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery – NEJM Evidence
News Release: Study finds fluorescent guide can help detect tumor left behind after breast cancer surgery – Mass General Brigham
EASL-ILCA Clinical practice guidelines on the management of intrahepatic cholangiocarcinoma
9 May, 2023 | 14:47h | UTC
Commentary on Twitter
?#CPG in press❕
EASL-ILCA Clinical Practice Guidelines on the management of #IntrahepaticCholangiocarcinoma
?Find it here?https://t.co/buM8rgBU1F@EASLedu@EASLnews#iCCA#LiverTwitter pic.twitter.com/raR983x0qk
— Journal of Hepatology (@JHepatology) April 20, 2023
M-A | Prevalence and outcomes of frailty in unplanned hospital admissions
9 May, 2023 | 14:45h | UTC
M-A | Enhanced Recovery after Surgery in patients with peritoneal malignancies undergoing cytoreductive surgery
9 May, 2023 | 14:43h | UTCRelated:
Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Review | Pediatric pericarditis
9 May, 2023 | 14:42h | UTCPediatric Pericarditis: Update – Current Cardiology Reports
Proposal of a new diagnostic algorithm for adult-onset Still’s disease
9 May, 2023 | 14:41h | UTCProposal of a new diagnostic algorithm for adult-onset Still’s disease – Clinical Rheumatology
Commentary on Twitter
Multicenter study of 80 AOSD & 60 controls used to develop AOSD criteria:
– 3 pts rash
– 3pts fever ≥ 39C
– 2 pts pharyngitis
– 2 pts arthritis
– 2 pts NLR ≥ 4
– 1 pt glycosyl ferritin ≤ 20%
7 pts = Dx (sens 92.5%) vs Yamaguchi(79%), Fautrel (76%) https://t.co/Amew1RHaA1 pic.twitter.com/dnJ6zVyfOW— Dr. John Cush (@RheumNow) February 8, 2023
Review | Estimating risk of antidepressant withdrawal from a review of published data
9 May, 2023 | 14:39h | UTCEstimating Risk of Antidepressant Withdrawal from a Review of Published Data – CNS Drugs
Commentary: Researchers Identify Factors to Predict Risk of Antidepressant Withdrawal – Mad in America
Review | Applications of artificial intelligence in breast pathology
9 May, 2023 | 14:36h | UTC
Review | Syndrome of inappropriate antidiuresis: from pathophysiology to management
9 May, 2023 | 14:37h | UTCSyndrome of Inappropriate Antidiuresis: From Pathophysiology to Management – Endocrine Reviews
SR | Educating health professionals in ultrasound guided peripheral intravenous cannulation
9 May, 2023 | 14:35h | UTC
A review of modern imaging landscape for prostate cancer: a comprehensive clinical guide
9 May, 2023 | 14:34h | UTC
M-A | Adverse events of cannabidiol use in patients with epilepsy
9 May, 2023 | 14:30h | UTC
RCT | Postoperative adjuvant anastrozole for 10 or 5 years in patients with hormone receptor–positive breast cancer
9 May, 2023 | 14:32h | UTCPostoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor–Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial – Journal of Clinical Oncology (link to abstract – $ for full-text)
Cohort Study | Long-term risk of epilepsy following invasive Group B Streptococcus disease in neonates
9 May, 2023 | 14:25h | UTC
M-A | Quality of life after risk-reducing surgery for breast and ovarian cancer prevention
9 May, 2023 | 14:21h | UTC